In reply to girlymonkey:
We use llama ABs in the lab all the time, mainly commercial ones against GFP and other proteins, as well as synthetic genes that express an antibody fused to a fluorescent protein to label some target inside the cell that produces the antibody.
This works best with llamas because they have one type of AB that is made from a single chain, and therefore, unlike normal mammalian ABs, does not require complex processing steps during assembly and secretion.
Screening for Llama ABs that bind to a given target such as CV spike protein is therefore also much easier. The drawback is that such single chain ABs are hard to "humanize", i.e. replacing all the bits that are not involved in antigen binding with pieces of human AB so that the AB does not by itself trigger an immune reaction.
CB